GILVETMAB
UNII 949NG8376D

Substance Identification & Data

This profile provides standardized clinical and technical data for Gilvetmab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 949NG8376D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1808081-43-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
949NG8376D
CAS Registry Number
1808081-43-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GILVETMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10528
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
DE-67
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gilvetmab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GILVETMAB

Common Names & Synonyms

GILVETMAB [INN]
GILVETMAB [USAN]
IMMUNOGLOBULIN GB, ANTI-(CANIS FAMILIARIS PROGRAMMED CELL DEATH PROTEIN 1) (CANIS FAMILIARIS-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISULFIDE WITH CANIS FAMILIARIS-MUS MUSCULUS LIGHT CHAIN, DIMER
PD-1 INHIBITOR (GILVETMAB)